ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Abstract: TH-PO1030

The Predictive Value of Crescents in Adult Henoch-Schölein Purpura Nephritis

Session Information

Category: Glomerular Diseases

  • 1203 Glomerular Diseases: Clinical, Outcomes, and Trials


  • Han, Fei, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, ZheJiang, China

To study the predictive value of crescents in adult Henoch-Schölein purpura nephritis(HSPN).


We retrospectively analyzed 275 adult patients with biopsy proven HSPN in the First Affiliated Hospital of Zhejiang University, and divided the patients into 4 groups: 99 patients in none crescent croup(NC), 34 patients in segmental crescents group(SC), 109 patients with circumferential crescents ≤25% were categorized into group C1, and 33 patients with crescents >25% were categorized into group C2. Data including serum creatinine(Scr), evaluated glomerular filtration rate(eGFR), 24h urine protein and mean arterial pressure were compared, and primary outcome was defined as ≥50% reduction of eGFR from baseline in 2 years, doubling of serum creatinine (Scr), or end stage renal disease (ESRD). ESRD was defined by reaching an eGFR of <15ml/min/1.72m2 or requiring maintaining renal replacement therapy for more than 3 months. Univariate analysis and multivariate analysis were used to compare the outcome.


There were no significant difference in gender or age(p>0.05). Differences in Scr(p=0.002), eGFR(p=0.007), 24h urine protein (p<0.001)were found significant. The median Scr level of NC, C1,C2, SC group were 59.0(51.0, 75.0)μmol/L,66.0(52.5, 77.0)μmol/L, 72.0 (55.0, 94.0) μmol/L, 68.0(56.5,118.0) μmol/L, respectively. Further analysis showed that patients with crescents (including segmental crescents) have a higher Scr level than those without crescents. The urine protein level of each group were 0.75(0.42,1.53),1.17(0.63,2.02)g, 1.60(0.86,3.00)g, 2.48(1.12,4.63) g, respectively. The median follow-up duration was 56(33,85) months, and 18 patients reached renal endpoint. Kaplan Meier analysis suggested that the renal outcomes were significantly different(p=0.002), the renal survival rates of NC, C1, C2, SC group were 96%, 88.1%, 78.8%, 100%, respectively. And Cox model suggested that a crescent ratio of more than 25% is an independent predictor of poor renal outcome.


A crescent ratio of more than 25% is an independent predictor of poor renal outcome in adult patients with Henoch-Schölein purpura nephritis.